Beta Bionics, Inc. (BBNX)
NASDAQ: BBNX · Real-Time Price · USD
10.87
+0.26 (2.45%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Beta Bionics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 482 | 1,341 | - | - | - |
| Enterprise Value | 271 | 1,120 | - | - | - |
| Last Close Price | 10.87 | 30.47 | - | - | - |
| PS Ratio | 4.81 | 13.38 | - | - | - |
| PB Ratio | 1.68 | 4.66 | - | - | - |
| P/TBV Ratio | 1.68 | 4.66 | - | - | - |
| EV/Sales Ratio | 2.70 | 11.18 | - | - | - |
| Debt / Equity Ratio | 0.03 | 0.03 | 0.10 | 0.07 | 0.32 |
| Net Debt / Equity Ratio | -0.74 | -0.74 | -1.27 | -1.58 | -1.81 |
| Net Debt / EBITDA Ratio | 3.02 | 3.02 | 2.18 | 2.67 | 0.37 |
| Net Debt / FCF Ratio | 3.77 | 3.77 | 1.86 | 2.82 | 0.39 |
| Asset Turnover | 0.42 | 0.42 | 0.50 | 0.17 | - |
| Inventory Turnover | 2.55 | 2.55 | 4.01 | - | - |
| Quick Ratio | 7.73 | 7.73 | 5.52 | 9.54 | 3.12 |
| Current Ratio | 8.66 | 8.66 | 6.29 | 9.77 | 3.21 |
| Return on Equity (ROE) | -40.26% | -40.26% | -81.35% | -123.17% | - |
| Return on Assets (ROA) | -18.73% | -18.73% | -21.78% | -30.79% | - |
| Return on Capital Employed (ROCE) | -24.10% | -24.10% | -35.20% | -36.10% | -242.90% |
| Earnings Yield | -15.17% | -5.46% | - | - | - |
| FCF Yield | -11.65% | -4.19% | - | - | - |
| Buyback Yield / Dilution | -536.74% | -536.74% | -20.01% | -6.13% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.